Search Results pharma ag
1.
Bayer Schering Pharma AG Will Terminate Registration With the U.S. SEC.
...PRNewswire-FirstCall/ -- Bayer Schering Pharma AG, Berlin, Germany will terminate its...Stockholders' Meeting of Bayer Schering Pharma AG on January 17, 2007 resolved to effect...the SEC means that Bayer Schering Pharma AG will no longer be subject to the...
June 4, 2007; PR Newswire
2.
Max Link Appointed Chairman of NOXXON Pharma AG.
...YORK, Feb. 20 /PRNewswire/ -- NOXXON Pharma AG announced today at the CEO &...Dr. Raimund Eckel, CEO of NOXXON Pharma AG. Dr. Max Link, 60, has held a number...career included 22 years at Sandoz Pharma AG (CEO from 1987 until 1992, Chairman...
February 20, 2001; PR Newswire
3.
Transdermal Patch and Subcutaneous Infusion.
BERLIN, June 4 /PRNewswire/ -- Axxonis Pharma AG today announces the submission of a marketing authorisation...quality of life on the subsequent day. About Axxonis Pharma AG Axxonis Pharma AG, Berlin, is a pharmaceutical company specialised on...
June 4, 2008; PR Newswire Europe
4.
ALTANA Pharma AG Selects Spotfire DecisionSite for Worldwide Use in Drug Discovery Research; Licensing agreement will support ALTANA Pharma AG with Guided Analytics.
...decision-making, today announced that ALTANA Pharma AG, a leading developer and manufacturer...discovery and clinical safety. ALTANA Pharma AG has signed a global licensing agreement...the Posters, scientists at ALTANA Pharma AG can share analysis findings and distribute...
November 1, 2004; Business Wire
5.
Offered by Schwarz Pharma Ag and its Competitors.
...Analyze the Products Offered by Schwarz Pharma Ag and its Competitors.(C)1994-2007...announced the addition of Schwarz Pharma Ag - Competitor Report to their offering The Schwarz Pharma Ag Competitor Report includes a business...
March 12, 2007; M2 Presswire
6.
NOXXON Pharma AG Demonstrates In Vivo Efficacy of Spiegelmers Against Intracellular Targets.
BERLIN -- NOXXON Pharma AG (NOXXON) today presented positive results...cardiovascular disease. About NOXXON Pharma AG, the next generation aptamer company...patent portfolio, Berlin-based NOXXON Pharma AG develops biostable aptamers, novel substances...
May 4, 2005; Business Wire
7.
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company.
BERLIN -- NOXXON Pharma AG (NOXXON) announced today the signing...specificity and affinity. About NOXXON Pharma AG: Based on one of the biggest and best...in the industry, Berlin-based NOXXON Pharma AG develops biostable aptamers, novel substances...
June 11, 2008; Business Wire
8.
NOXXON Pharma AG Appoints Daniel Levitt, M.D., Ph.D., as Chairman of Clinical Advisory Board.
BERLIN -- NOXXON Pharma AG (NOXXON) today announced the appointment...aptamers, said Dr. Levitt. About NOXXON Pharma AG, the next generation aptamer company...patent portfolios, Berlin-based NOXXON Pharma AG develops biostable aptamers, novel substances...
August 25, 2005; Business Wire
9.
Novartis Pharma AG, Pfizer Inc.& Schering-Plough Corporation are Just Some of the Leading Companies Operating in the Asthma Therapeutics Market.
...2006-Research and Markets: Novartis Pharma AG, Pfizer Inc.& Schering-Plough...such as Abbott Laboratories, ALTANA Pharma AG, AstraZeneca, Boehringer Ingelheim...Merck & Co., Inc., Novartis Pharma AG, Pfizer Inc., Schering-Plough Corporation...
November 29, 2006; M2 Presswire
10.
Novartis Pharma AG and BioTransplant Create New Xenotransplantation Research Company.
...Sept. 26 /PRNewswire/ -- Novartis Pharma AG and BioTransplant Incorporated (Nasdaq...the field individually, Novartis Pharma AG and BioTransplant believe that they...wholly owned subsidiary of Novartis Pharma AG, into one, independent company which...
September 26, 2000; PR Newswire
|
